About STM
STM is a company based in Farmington (United States) founded in 2022 by Jasdeep Singh and Thanh Duc Nguyen. STM has raised $350 thousand across 1 funding round from investors including Health Advance Partners. STM offers products and services including Microneedle Patch and Vaccine Platform. STM operates in a competitive market with competitors including Enable Injections, Micron Biomedical, Zosano Pharma, Raphas and SkinJect, among others.
- Headquarter Farmington, United States
- Founders Jasdeep Singh, Thanh Duc Nguyen
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$350 K (USD)
in 1 rounds
-
Latest Funding Round
$350 K (USD), Seed
Jan 11, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of STM
STM offers a comprehensive portfolio of products and services, including Microneedle Patch and Vaccine Platform.
Patch delivers vaccines and therapeutics via skin for improved immunity.
System for multi-dose release without cold chain or boosters.
People of STM
Unlock access to complete
Unlock access to complete
Funding Insights of STM
STM has successfully raised a total of $350K through 1 strategic funding round. The most recent funding activity was a Seed round of $350 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in STM
STM has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Health Advance Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for STM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by STM
Investment portfolio details for STM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - STM
Detailed financials for STM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stm Comparisons
Peer comparison for STM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of STM
STM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enable Injections, Micron Biomedical, Zosano Pharma, Raphas and SkinJect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a wearable drug delivery solution
|
|
| Locked | Locked | Locked |
Microneedle patches are developed for vaccine and drug delivery.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
|
| Locked | Locked | Locked |
Microneedle technology is developed for cosmetics and medical applications.
|
|
| Locked | Locked | Locked |
Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed.
|
Detailed competitors of STM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stm
Complete news archive for STM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STM
STM was founded in 2022 and raised its 1st funding round 2 years after it was founded.
STM is headquartered in Farmington, United States.
Jasdeep Singh is the current CEO of STM. They have also founded this company.
STM is a funded company, having raised a total of $350K across 1 funding round to date.
STM was founded in 2022 in Farmington, United States, by co-founders Jasdeep Singh and Thanh Duc Nguyen. Transdermal patches for vaccine delivery are developed by the company within the medical device sector. The SingleTimeMicroneedle product is utilized, featuring bodily degradable microneedles that are embedded into the skin without pain. Operations focus on innovative immunization methods, with the domain stmpatch.com serving as the primary online presence.
STM's top competitors include Enable Injections, Micron Biomedical and SkinJect.
STM offers Microneedle Patch and Vaccine Platform.
STM has 1 investor. Key investors include Health Advance Partners.